Pfizer

Pfizer’s TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer

The HER2CLIMB-05 trial is a randomized, double blind, placebo-controlled, pivotal Phase 3 study evaluating the efficacy and safety of TUKYSA compared to placebo, both in combination with trastuzumab ...
Mirage News

FDA Approves Pfizer's TUKYSA for Front-Line HER2+ Breast Cancer Maintenance

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TUKYSA® (tucatinib) in combination with ...
Yahoo Finance

Pfizer (PFE) After FDA Vaccine Approval Faces A Fair Value Reality Check

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hosted on MSN

FDA approves latest version of Pfizer's COVID-19 mRNA vaccine

Aug. 27 (UPI) --Pfizer and BioNTech announced Thursday that the Food and Drug Administration has approved a newly updated version of their COVID-19 vaccine, which has been formulated to attack the now ...